Counterfeit peptide red flags
How counterfeit peptides actually appear in the research-chem market — common substitutions, how mass spec catches them, and how to test if you suspect one.
Updated May 7, 2026 · 6 min read
Counterfeit peptides are an under-discussed risk in research-chem sourcing. The standard quality conversation focuses on purity and endotoxin — both important — but assumes the peptide in the vial is at least the molecule on the label. A subset of vendors don't sell low-purity peptide; they sell the wrong peptide entirely, labeled as something else. Understanding how this happens, what the common substitutions are, and how to verify identity is the third leg of the quality stool.
What "counterfeit" means in the peptide market
Counterfeit, in this context, means the molecule in the vial is not the molecule on the label. This is distinct from low purity (the right molecule, plus impurities) and distinct from contamination (the right molecule, plus unwanted bacterial fragments). Common counterfeit patterns:
| Pattern | What it looks like |
|---|---|
| Cheaper peptide labeled as expensive one | Substitution with a structurally simpler peptide |
| Related peptide labeled as the target | TB-500 fragment vs full TB4, GHK vs GHK-Cu |
| Generic short peptide labeled as branded one | Random sequence sold as "BPC-157" |
| Mixed labels | Same powder repackaged under different product names |
The economic incentive is straightforward: cheaper peptides cost less to produce, and the user has no easy way to verify identity without lab equipment.
The most common counterfeits
A few patterns come up repeatedly in user reports and independent testing:
TB-500 mislabeled as full TB4 (or vice versa)
TB-500 is a 17-amino-acid fragment of thymosin beta-4. Full TB4 is the 43-amino-acid parent protein. The two have related but distinct activity profiles, and full TB4 is significantly more expensive to produce. Vendors sometimes sell one as the other:
- Full TB4 sold as TB-500 — user gets a different molecule with somewhat different activity
- Cheaper short peptide sold as TB-500 — user gets something with little to no relevant activity
Mass spectrometry distinguishes the two cleanly; the molecular weights are very different.
IGF-1 LR3 substituted with cheaper peptides
IGF-1 LR3 is one of the more expensive peptides in the strength market — it's a complex molecule and difficult to produce at high purity. That makes it a prime substitution target. Reports of "IGF-1 LR3" that turned out to be entirely different peptides are common.
A vial of IGF-1 LR3 should produce a specific molecular weight signature on mass spec. If the COA doesn't include mass spec data, identity is unverified.
GHK without copper sold as GHK-Cu
GHK and GHK-Cu are the same tripeptide — what makes the difference is the bound copper ion. GHK-Cu is what most of the documented activity is associated with; uncomplexed GHK is significantly less active. Some vendors sell GHK and label it GHK-Cu, or use insufficient copper in the complexation step.
Visual cue: GHK-Cu is blue (the copper-tripeptide complex has a characteristic blue color). A "GHK-Cu" vial that's white or off-white is missing the copper.
Generic peptides labeled as BPC-157
BPC-157 is a 15-amino-acid sequence. Some counterfeit vials contain shorter generic peptides with no relationship to BPC-157, sold under the BPC-157 label. Users running these typically report no effects in either direction — the molecule isn't doing anything specific.
Ipamorelin / GHRP / hexarelin confusion
GH secretagogues are a family of related molecules. Ipamorelin, GHRP-2, GHRP-6, and hexarelin all stimulate GH release through similar mechanisms but with different side-effect profiles. Mislabeling within this family produces results that look "like ipamorelin but with cortisol bumps and hunger" — that's GHRP-6 sold as ipamorelin.
How mass spec catches counterfeits
Mass spectrometry measures the molecular weight of a peptide. Each peptide has a specific theoretical mass based on its amino acid sequence. The COA's identity section compares the observed mass to the theoretical mass:
| Result | Interpretation |
|---|---|
| Observed matches theoretical (within ~1 Da) | Identity confirmed |
| Observed differs by amino acid mass | Wrong sequence |
| Observed differs by larger amount | Substitution with different molecule |
| No mass spec data on COA | Identity unverified |
A counterfeit cannot pass mass spec. If the vial contains a different molecule, the mass will be different, and any honest analytical lab will report the discrepancy.
This is why "no mass spec on COA" is a different kind of red flag from "low purity." Low purity tells you about quality. Missing mass spec tells you the vendor hasn't verified the molecule is what's labeled.
How to test if you suspect a counterfeit
If a vial behaves nothing like the peptide should — particularly if it's IGF-1 LR3, TB-500, or GHK-Cu — independent testing is an option:
- Find a third-party analytical lab that runs peptide identity testing
- Send a small portion of the vial (a few mg is typically enough for mass spec)
- Pay for identity confirmation — typically 100 to 200 USD for mass spec on a single sample
- Compare results to the labeled peptide's theoretical mass
If the results don't match, you have evidence of misidentification. Some vendors will replace product when shown third-party identity test results contradicting their COA; some won't. Either way, you've learned something about the vendor.
Pricing as a signal
Counterfeit-prone peptides tend to be the more expensive ones — IGF-1 LR3, GHK-Cu, full TB4. Pricing dramatically below the market range for those specific peptides is a flag worth taking seriously. The economics of producing the real molecule have a floor; vendors selling consistently below that floor are either subsidizing as a loss leader or selling something else.
| Pricing relative to market | Counterfeit risk |
|---|---|
| At or above market | Lower |
| Slightly below market | Variable |
| Dramatically below market | Higher |
| "Too good to be true" | Often is |
Marketplace listings
Marketplace listings — eBay, Amazon (rare for peptides but it happens), Alibaba direct, generic e-commerce platforms — are the highest-counterfeit category. Quality control is essentially absent, and the seller's identity is often opaque. Established research-chem vendors with their own websites and COAs are a different risk category from marketplace sellers entirely.
What protects against counterfeits
The same things that protect against other quality issues:
- COAs from independent labs with mass spec identity testing
- Vendor history (years not months)
- Independent reviews on neutral platforms
- Reasonable pricing
- Test orders before committing to bulk
For the broader vendor-evaluation framework, see choosing a peptide vendor.
When counterfeits get caught
Most counterfeits get exposed through a combination of independent testing by suspicious users and forum reports of effects (or non-effects) inconsistent with the labeled peptide. The pattern:
- Users in a community start reporting unusual results from a specific vendor
- Someone with the resources runs independent testing
- Results circulate in the community
- The vendor either issues an explanation (often unconvincing) or quietly disappears
The community-level signal often precedes formal verification by months. Reading current forum discussions before placing an order is part of the work.
The bottom line
Counterfeits are a real failure mode in research-chem peptides, particularly for the more expensive molecules. Mass spec on the COA is what verifies identity. A COA without mass spec data is incomplete. If a vial behaves nothing like the labeled peptide, independent testing for 100 to 200 USD answers the question definitively.